Microfluidics and nanotechnology offer exciting possibilities for Cancer Diagnostics by leveraging the properties of tiny-scale fluid dynamics and materials engineering. These technologies enable the development of miniature devices capable of capturing and analyzing circulating tumor cells (CTCs) or cancer-related biomarkers from bodily fluids. Microfluidic devices can isolate and characterize CTCs, providing valuable information about tumor heterogeneity and potential metastatic potential. Additionally, nanotechnology-based sensors can detect cancer-specific biomarkers with high sensitivity and specificity, allowing for early cancer detection and monitoring of treatment response.

Explore More- https://coherentmarketinsightsus.blogspot.com/2023/06/next-generation-tools-for-cancer.html